Incidence of Vitiligo During Biologic Treatment: A Systematic Review
收藏Mendeley Data2026-04-09 收录
官方服务：
资源简介：
Incidence of Vitiligo During Biologic Treatment: A Systematic Review Tables
生物治疗期间白癜风的发病率：一项系统综述的附表
应用场景：
相关数据集
面向纳米酶安全应用的新评价指标与评价方法研究数据集
该数据集对多种常见的纳米酶进行了较为全面的安全性评价，对纳米酶的生物医学应用具有重要的意义。数据主要包括：以氧化铁为代表的多种纳米酶的结构、理化性质表征、对内皮细胞连接、诱导内皮间质转分化的研究的数据、图片及文件。数据量约155 MB。
国家基础学科公共科学数据中心180
Supplementary Materials_JAAD-D-24-02448
No Difference in Risk of Major Adverse Cardiovascular Events and Venous Thromboembolic Events Between Patients With Psoriasis or Psoriatic Arthritis on Tumor Necrosis Factor Inhibitors, Interleukin-17
NIAID Data Ecosystem40
Dataset from A Non-Randomized, Open-Label, Roll-Over Study With Self Injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
The purpose of this study is to evaluate the long-term safety of subcutaneous (SC) self-injections (by the subject or subject's family member) of adalimumab in adult Japanese subjects with Rheumatoid
NIAID Data Ecosystem20
Spodoptera frugiperda Sf-RVN cell line Genome and Transcriptome sequencing and assembly. Spodoptera frugiperda isolate:Sf-RVN
We recently isolated Sf-RVN, a new Spodoptera frugiperda (Sf) cell line that unlike other Sf cell lines is not persistently infected with Sf-rhabdovirus. Here, we used massively parallel sequencing (M
NIAID Data Ecosystem100
Treatment-emergent Candida infections in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis treated with ixekizumab: an integrated safety analysis of 25 clinical studies
This safety analysis investigates treatment-emergent mucosal/cutaneous Candida infections in patients treated with ixekizumab (IXE), an anti-interleukin-17A monoclonal antibody, across the approved in
Taylor & Francis Group2024-10-10 更新30
